{"organizations": [], "uuid": "e79cf9b5301be504eee2324729d7aaa4b60b1275", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-catalyst-pharmaceuticals-announces/brief-catalyst-pharmaceuticals-announces-plans-to-resubmit-new-drug-application-for-firdapse-idUSFWN1Q20U8", "country": "US", "domain_rank": 408, "title": "BRIEF-Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-12T15:11:00.000+02:00", "replies_count": 0, "uuid": "e79cf9b5301be504eee2324729d7aaa4b60b1275"}, "author": "", "url": "https://www.reuters.com/article/brief-catalyst-pharmaceuticals-announces/brief-catalyst-pharmaceuticals-announces-plans-to-resubmit-new-drug-application-for-firdapse-idUSFWN1Q20U8", "ord_in_thread": 0, "title": "BRIEF-Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "none"}, {"name": "reuters) - catalyst pharmaceuticals inc", "sentiment": "none"}, {"name": "nda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "firdapse reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 11 PM / Updated 11 minutes ago BRIEF-Catalyst Pharmaceuticals Announces Plans To Resubmit New Drug Application For Firdapse Reuters Staff \nFeb 12 (Reuters) - Catalyst Pharmaceuticals Inc: \n* CATALYST PHARMACEUTICALS ANNOUNCES PLANS TO RESUBMIT NEW DRUG APPLICATION FOR FIRDAPSEÂ® \n* CATALYST PHARMACEUTICALS - CURRENTLY ANTICIPATES RESUBMITTING NDA FOR FIRDAPSE FOR LEMS TO FDA BY END OF Q1 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-12T15:11:00.000+02:00", "crawled": "2018-02-12T15:36:08.009+02:00", "highlightTitle": ""}